These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10882346)

  • 1. Physiological aspects of low-density lipoprotein oxidation.
    Thomas MJ
    Curr Opin Lipidol; 2000 Jun; 11(3):297-301. PubMed ID: 10882346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized lipoproteins, altered cell function and atherosclerosis.
    Penn MS; Chisolm GM
    Atherosclerosis; 1994 Aug; 108 Suppl():S21-9. PubMed ID: 7802725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.
    Navab M; Berliner JA; Subbanagounder G; Hama S; Lusis AJ; Castellani LW; Reddy S; Shih D; Shi W; Watson AD; Van Lenten BJ; Vora D; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):481-8. PubMed ID: 11304461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized lipoproteins and nitric oxide.
    Jessup W
    Curr Opin Lipidol; 1996 Oct; 7(5):274-80. PubMed ID: 8937516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes.
    Adams MR; Kinlay S; Blake GJ; Orford JL; Ganz P; Selwyn AP
    Annu Rev Med; 2000; 51():149-67. PubMed ID: 10774458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of differently oxidized LDL on the expression of pro-inflammatory molecules in human monocytes in vitro.
    Dominaitiene R; Lindgren S; Janciauskiene S
    In Vitr Mol Toxicol; 2001; 14(2):83-97. PubMed ID: 11690562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis.
    Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Arai H; Kawai C
    Eur Heart J; 1990 Aug; 11 Suppl E():122-7. PubMed ID: 2226520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
    Tsimikas S; Shortal BP; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond oxidized LDL: the initiation and progression of atherosclerosis.
    Hirose N; Arai Y; Kawamura M; Shigematu H
    Keio J Med; 1996 Jun; 45(2):90-4. PubMed ID: 8683904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies.
    Albertini R; Moratti R; De Luca G
    Curr Mol Med; 2002 Sep; 2(6):579-92. PubMed ID: 12243250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized LDL and atherogenesis.
    Ylä-Herttuala S
    Ann N Y Acad Sci; 1999 Jun; 874():134-7. PubMed ID: 10415527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why are low-density lipoproteins atherogenic?
    Young SG; Parthasarathy S
    West J Med; 1994 Feb; 160(2):153-64. PubMed ID: 8160466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein oxidation and atherosclerosis.
    Young IS; McEneny J
    Biochem Soc Trans; 2001 May; 29(Pt 2):358-62. PubMed ID: 11356183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
    Tertov VV; Kaplun VV; Orekhov AN
    Mol Cell Biochem; 1998 Jun; 183(1-2):141-6. PubMed ID: 9655188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protection of oxidation of LDL by nitric oxide: implication in atherogenesis].
    Maggi MF; Cristol JP; Guérin MC; Descomps B; Torreilles J
    C R Seances Soc Biol Fil; 1995; 189(3):375-87. PubMed ID: 8521086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.